Lilly to acquire Merida Biosciences in deal worth up to $2.875bn PMLiVE 6d PMLiVE 6d Central America Pharma Latin America All sources
Eli Lilly has been on an acquisition spree. How much could its latest deals boost the stock? The Motley Fool 8h The Motley Fool 8h Mounjaro Novo Nordisk Pharma All sources
Is Eli Lilly stock outperforming the Dow? Barchart 11:37 Fri, 28 Aug Barchart 11:37 Fri, 28 Aug Pharma
Eli Lilly is acquiring merdia biosciences for up to $2.88 Billion. Here's what that means for investors. The Motley Fool 7d The Motley Fool 7d Central America Pharma Biotechnology
Has Novo Nordisk finally found the catalyst that could flip the script on Eli Lilly? The Motley Fool 00:46 Sun, 30 Aug The Motley Fool 00:46 Sun, 30 Aug Novo Nordisk Mounjaro Pharma All sources
Here's why billionaires Stanley druckenmiller and Ken Griffin are loading up on Eli Lilly stock The Motley Fool 2d The Motley Fool 2d Ken Griffin Pharma
Eli Lilly Has Been on an Acquisition Spree. How Much Could Its Latest Deals Boost the Stock? The Motley Fool 22:34 Mon, 07 Sep
Here's Why Billionaires Stanley Druckenmiller and Ken Griffin Are Loading Up on Eli Lilly Stock The Motley Fool 10:19 Sun, 06 Sep
Prediction: Here's What a $5,000 Investment in Eli Lilly Could Look Like in 5 Years The Motley Fool 22:17 Sat, 05 Sep
Will Eli Lilly Split Its Stock? Here's What History Says Will Happen If It Does. The Motley Fool 19:44 Sat, 05 Sep
Superluminal Medicines Announces Oversubscribed $60 Million Series B Financing to Advance Lead Program in Rare Genetic Forms of Obesity into the Clinic PR Newswire (Press Release) 11:04 Thu, 03 Sep
Nxera Pharma Secuces $8.6 Million Milestone Payment From Centessa Following Late-stage Progress RTT News 09:01 Thu, 03 Sep
Doctors urge health ministry to address Mounjaro price gap as illegal imports surge Korea Biomedical Review 05:57 Thu, 03 Sep